_version_ 1784664317954621440
author Moreno-Ramírez, David
Duarte-Ferreras, Miguel A.
Ojeda-Vila, Teresa
García-Morales, Irene
Conejo-Mir, Maria D.
Fernández-Orland, Almudena
Sánchez-del-Campo, Ana I.
Eiris, Noemí
Carrizosa, Ana M.
Ruiz-de-Casas, Andrés
de-la-Torre, Jose M.
Herrerías-Esteban, Juan M.
Ferrándiz, Lara
author_facet Moreno-Ramírez, David
Duarte-Ferreras, Miguel A.
Ojeda-Vila, Teresa
García-Morales, Irene
Conejo-Mir, Maria D.
Fernández-Orland, Almudena
Sánchez-del-Campo, Ana I.
Eiris, Noemí
Carrizosa, Ana M.
Ruiz-de-Casas, Andrés
de-la-Torre, Jose M.
Herrerías-Esteban, Juan M.
Ferrándiz, Lara
author_sort Moreno-Ramírez, David
collection PubMed
description
format Online
Article
Text
id pubmed-8901237
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier on behalf of the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-89012372022-03-08 Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study Moreno-Ramírez, David Duarte-Ferreras, Miguel A. Ojeda-Vila, Teresa García-Morales, Irene Conejo-Mir, Maria D. Fernández-Orland, Almudena Sánchez-del-Campo, Ana I. Eiris, Noemí Carrizosa, Ana M. Ruiz-de-Casas, Andrés de-la-Torre, Jose M. Herrerías-Esteban, Juan M. Ferrándiz, Lara J Am Acad Dermatol Research Letter Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2022-11 2022-03-07 /pmc/articles/PMC8901237/ /pubmed/35271937 http://dx.doi.org/10.1016/j.jaad.2022.03.004 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Moreno-Ramírez, David
Duarte-Ferreras, Miguel A.
Ojeda-Vila, Teresa
García-Morales, Irene
Conejo-Mir, Maria D.
Fernández-Orland, Almudena
Sánchez-del-Campo, Ana I.
Eiris, Noemí
Carrizosa, Ana M.
Ruiz-de-Casas, Andrés
de-la-Torre, Jose M.
Herrerías-Esteban, Juan M.
Ferrándiz, Lara
Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
title Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
title_full Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
title_fullStr Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
title_full_unstemmed Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
title_short Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
title_sort telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the covid-19 pandemic: a longitudinal prospective feasibility study
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901237/
https://www.ncbi.nlm.nih.gov/pubmed/35271937
http://dx.doi.org/10.1016/j.jaad.2022.03.004
work_keys_str_mv AT morenoramirezdavid telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT duarteferrerasmiguela telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT ojedavilateresa telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT garciamoralesirene telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT conejomirmariad telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT fernandezorlandalmudena telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT sanchezdelcampoanai telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT eirisnoemi telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT carrizosaanam telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT ruizdecasasandres telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT delatorrejosem telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT herreriasestebanjuanm telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy
AT ferrandizlara telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderatetosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy